Marijke Vroomen Durning
Idelalisib Combination Trial for CLL Unblinded One Year Early
Marijke Vroomen Durning, RN 11/19/2015 0
A phase III study of idelalisib (Zydelig) combination therapy for the treatment of relapsed chronic lymphocytic leukemia (CLL) has been unblinded a year early, as recommended by an ...
Should We Obtain CA 19-9 Levels on All Pancreatic Cancer Patients?
Lori Smith, BSN, MSN, CRNP 11/16/2015 0
For years, the standard approach to treating operable pancreatic cancer was to perform surgery, then give subsequent chemotherapy; however, researchers now say that this strategy ...
Cancer Survivorship – A Blessing and a Challenge in Healthcare
Tambre Leighn, MA, CPC, ELI-MP, Founder & CEO, WellBeyondOrdinary.com 11/5/2015 1
The good news about cancer? By January 1, 2024, it is estimated that the population of cancer survivors will increase to almost 19 million: 9.3 million males and 9.6 million ...